The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
FDA has approved Bylvay (odevixibat), the first treatment for pruritus (moderate to severe itching) in patients aged three months and older with ...
read more
The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) in combination with pomalidomide and dexamethasone for ...
read more
AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer...
read more
The FDA Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted 13 to 1 that the benefit-risk profile of roxadustat does not support ...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has...
read more
Alkeus Pharmaceuticals, Inc., a private, late-stage biopharmaceutical company, announced that the U.S. FDA granted Breakthrough Therapy Designation to...
read more
Kriya Therapeutics, a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, announced the closing of a $...
read more
Spanish biopharmaceutical company Biofabri and IAVI, an international nonprofit research organization focused on developing vaccines and antibodies ...
read more
Curia, formerly AMRI, agreed to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing ...
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective ...
read more
AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the ...
read more
SRI International (SRI) announced a drug discovery research collaboration with Sanofi. By leveraging SRI’s SynFini™ platform, an artificial ...
read more
Merck announced plans to withdraw the U.S. accelerated approval indication for KEYTRUDA (pembrolizumab) for treatment of patients with recurrent ...
read more
GM Biopharmaceuticals, Inc. announced that the company has entered into an amended and restated agreement with Merck to extend their ongoing ...
read more
AstraZeneca has appointed Dr. Susan Galbraith to lead Oncology Research & Development. Her appointment follows the passing of José Baselga earlier ...
read more